Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Outpatient (ex Primary Care)

 

Interview: Mark Hellowell, Lecturer, University of Edinburgh

Hellowell is a healthcare academic who specialises in PPPs, evaluating their performance around the world, consulting with development agencies and acting as a special adviser to the Health Select Committee in the British House of Commons. He also lectures on healthcare reform to a diverse group of postgraduate students, many of them from developing countries. We talk to him about the role private healthcare companies can, and are, playing in the developing and developed worlds, the future for PPPs, and whether they are “a good thing”.

Amedes buys Medivision

Amedes, the big German lab group, has bought Medivision, the endocrinology chain, from the receivers. We reveal the sum paid, and look at EBITDA margins. How does this fit with the ongoing sale of Amedes?

Polish health group ScanMed looks for investor

ScanMed, a diverse Polish healthcare group, is looking for a strategic investor. We look at the group and who might buy it. Meanwhile, Bupa-owned LUX MED has bought an 81% stake in Carolina Medical Center.

Interview: Stuart Fletcher, CEO, Bupa

It has been a busy year for insurer, hospital operator and care group Bupa. New CEO Stuart Fletcher is spending roughly £1.25bn to buy businesses in half a dozen countries across the world. That includes the planned acquisition of Cruz Blanca, a Chilean service provider and insurer, as well as the purchases of Quality HealthCare (a network of 102 outpatient clinics and 500 affiliates in Hong Kong), Richmond Villages (an assisted living business in the UK), LUX MED (the largest subscription healthcare operator in Poland), ten nursing homes in Australia, and dentists here, there and everywhere. All this is part of the Bupa 2020 master plan, which will see the world’s largest player in ex-pat insurance deliver far more integrated care. We talk to Fletcher to find out more.

Medivision for sale

Medivision - with 685 employees, probably the largest outpatient chain in Germany - has sought protection from its creditors after its majority-owner was imprisoned for fraud. The business, which claimed sales of over €80m in 2010, is now for sale.

Interview: Anna Herkmen, Eastern Europe Supervisor, Acibadem

Largest Turkish hospital group Acibadem is making a big play for international patients in the Balkans. The company is 75%-owned by Malaysian investment fund Khazanah Nasional and listed operator IHH Healthcare, and 25%-owned by the founding Aydinlar family. Acibadem runs 16 hospitals and nine outpatient clinics in Turkey, and owns 50.7% of Sistina hospital in Macedonia. The group is looking particularly hard at Romania, where 1,000 patients travelled to Acibadem for treatment in 2012. We talk to Anna Herkmen, head of Acibadem’s efforts in East Europe, to find out more.

Al Noor makes troubled offering

Abu Dhabi-based hospital and clinic operator Al Noor has listed on the London Stock Exchange. The group runs three hospitals, two satellite clinics offering a mix of ambulatory and overnight beds and a family care clinic. Al Noor earned EBITDA of around US$70m on sales of $324.4m, for a net profit of $60.5m in 2012. This is up 11% from 2011 sales of $292.9m, with net profit up 19% from $50.8m. The group has a 35% share of Abu Dhabi’s private outpatient market and 39% share of its inpatient market. So how did the float go?

MediGroup is Serbia’s first big chain

Blue Sea Capital has made a third acquisition in Serbia ahead of the launch of MediGroup, the first big branded healthcare chain in the country.

Find Us